Van Tuyl Christopher
SEC CIK 1779707 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | CLO | 179.4K | — | $1.31M | 10 | 2024-12-16 | 2026-07-08 |
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-07-10 16:13 | 2026-07-08 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | S - Sale | $39.55 | -1,206 | 179.4K | -0.7% | -$47.7K |
| D | 2026-06-26 19:45 | 2026-06-26 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | M - OptEx | $15.20 | +17.8K | 198.4K | +10% | +$270.9K |
| DM | 2026-06-26 19:45 | 2026-06-26 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | S - Sale+OE | $38.31 | -17.8K | 180.6K | -9% | -$682.9K |
| 2026-06-22 16:02 | 2026-06-18 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | S - Sale | $35.39 | -2,634 | 180.6K | -1% | -$93.2K | |
| 2026-04-10 16:05 | 2026-04-08 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | S - Sale | $24.83 | -5,165 | 183.2K | -3% | -$128.2K | |
| D | 2026-04-09 16:17 | 2026-04-07 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | A - Grant | $0.00 | +41.3K | 188.4K | +28% | $0 |
| 2026-03-20 | 2026-03-18 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | S - Sale | $24.97 | -2,877 | 147.1K | -2% | -$71.8K | |
| M | 2025-12-19 | 2025-12-18 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | S - Sale | $26.91 | -10.8K | 152.2K | -7% | -$290.9K |
| D | 2025-04-03 | 2025-04-01 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | A - Grant | $0.00 | +50.8K | 160.7K | +46% | $0 |
| D | 2024-12-18 | 2024-12-16 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | CLO | A - Grant | $0.00 | +110.0K | 110.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations